ArticleDiabetes care2013

Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.

Pieter Gillard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.